Inventor
DELORME DANIEL
CA38 patents
⚠️ This page may combine multiple inventors who share the name “DELORME DANIEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
METHYLGENE INC
11 patentsUS6897220B2May 24, 2005
Inhibitors of histone deacetylase
METHYLGENE INC121 citations98
US6541661B1Apr 1, 2003
Inhibitors of histone deacetylase
METHYLGENE INC192 citations97
US7253204B2Aug 7, 2007
Inhibitors of histone deacetylase
METHYLGENE INC69 citations96
US7838520B2Nov 23, 2010
Inhibitors of histone deacetylase
METHYLGENE INC20 citations91
USRE39850ESep 18, 2007
Inhibitors of histone deacetylase
METHYLGENE INC34 citations91
US6472406B1Oct 29, 2002
Sulfonamidomethyl phosphonate inhibitors of beta-lactamase
METHYLGENE INC28 citations91
US7288567B2Oct 30, 2007
Inhibitors of histone deacetylase
METHYLGENE INC13 citations84
US7868204B2Jan 11, 2011
Inhibitors of histone deacetylase
METHYLGENE INC16 citations83
US7595343B2Sep 29, 2009
Inhibitors of histone deacetylase
METHYLGENE INC17 citations83
US7282608B2Oct 16, 2007
Inhibitors of histone deacetylase
METHYLGENE INC12 citations83
US7030103B2Apr 18, 2006
Sulfonamidomethyl phosphonate inhibitors of β-lactamase
METHYLGENE INC1 citations51
MERCK FROSST CANADA INC
10 patentsUS5093356AMar 3, 1992
Indenyl hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase
MERCK FROSST CANADA INC59 citations96
US5576338ANov 19, 1996
Bis (biaryl) compounds as inhibitors of leukotriene biosynthesis
MERCK FROSST CANADA INC53 citations95
US5552437ASep 3, 1996
Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
MERCK FROSST CANADA INC23 citations92
US5527827AJun 18, 1996
Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis
MERCK FROSST CANADA INC26 citations92
US5202321AApr 13, 1993
Thiopyrano[2,3,4-c,d]indoles as inhibitors of leukotriene biosynthesis
MERCK FROSST CANADA INC24 citations92
US5308852AMay 3, 1994
Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
MERCK FROSST CANADA INC23 citations91
US5252599AOct 12, 1993
Heteroarylnaphthalene hydroxy acids as inhibitors of leukotriene biosynthesis
MERCK FROSST CANADA INC9 citations74
US5132319AJul 21, 1992
1-(hydroxylaminoalkyl) indole derivatives as inhibitors of leukotriene biosynthesis
MERCK FROSST CANADA INC19 citations74
US5428060AJun 27, 1995
Heteroarylnaphthalene lactones as inhibitors of leukotriene biosynthesis
MERCK FROSST CANADA INC4 citations63
US5314900AMay 24, 1994
Aryl thiopyrano[2,3,4-C,D]indoles as inhibitors of leukotriene biosynthesis
MERCK FROSST CANADA INC3 citations63
ASTRAZENECA CANADA INC
6 patentsUS6455545B2Sep 24, 2002
Compounds with analgesic effect
ASTRAZENECA CANADA INC45 citations96
US6693117B2Feb 17, 2004
Compounds with analgesic effect
ASTRAZENECA CANADA INC14 citations92
US7312336B2Dec 25, 2007
Compounds with analgesic effect
ASTRAZENECA CANADA INC7 citations73
US6387949B1May 14, 2002
Substituted urea compounds useful in pain management
ASTRAZENECA CANADA INC7 citations61
US6376534B1Apr 23, 2002
Compounds useful in pain management
ASTRAZENECA CANADA INC1 citations51
US6777561B1Aug 17, 2004
Compounds
ASTRAZENECA CANADA INC0 citations40
BELLUS HEALTH INC
3 patentsUS8044100B2Oct 25, 2011
Methods and compositions for treating amyloid-related diseases
BELLUS HEALTH INC9 citations81
US11020360B2Jun 1, 2021
Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
BELLUS HEALTH INC1 citations71
US10857109B2Dec 8, 2020
Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
BELLUS HEALTH INC3 citations71